Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-21 | Kronos Bio, Inc. | Olek Elizabeth A
(SR VP, CLINICAL SCIENCE) |
S | Common Stock | D | 7368 | $1.05 - $1.05 | $7,765 |
| 2024-02-21 | Kronos Bio, Inc. | Lin Charles Y
(SR VP, RESEARCH & DEVELOPMENT) |
S | Common Stock | D | 12036 | $1.05 - $1.05 | $12,684 |
| 2024-02-21 | Kronos Bio, Inc. | Frisbee Allison
(SR VP, CORP OPERATIONS & LEGAL) |
S | Common Stock | D | 12105 | $1.05 - $1.05 | $12,757 |
| 2024-02-15 | Kronos Bio, Inc. | BISCHOFBERGER NOR...
(PRESIDENT & CEO) |
A | Common Stock | A | 270339 | $0.00 - $0.00 | $0 |
| 2023-12-12 | Kronos Bio, Inc. | Dinsmore Christopher
(Chief Scientific Officer) |
S | Common Stock | D | 10032 | $1.30 - $1.30 | $13,091 |
| 2023-11-15 | Kronos Bio, Inc. | BISCHOFBERGER NOR...
(President & CEO) |
P | Common Stock | A | 1731056 | $0.80 - $1.08 | $1,470,393 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |